Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05931913 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TMS + Exposure Therapy for Pediatric OCD

Study acronym: NExT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 years 2 months later Jun 30, 2026 → Aug 31, 2029
See other at-risk trials from Bradley Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment reopened
    • Enrollment increased: 50 → 60 participants
    • Site details revised at 2 of 2 sites
    v7
  2. Primary completion pushed from Jun 30, 2026 to Aug 31, 2029
    • Study completion pushed from Jul 31, 2026 to Oct 31, 2029
    v6
  3. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 60 to confirmed 50
    • Site details revised at 2 of 2 sites
    v5
  4. Primary completion date: Jun 30, 2025 to Jun 30, 2026
    • Study completion date: Jul 31, 2025 to Jul 31, 2026
    • Site contacts updated at 1 of 2 sites
    v4
  5. Start date changed from estimate of Feb 15, 2024 to Mar 20, 2024v3
  6. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Start date: Oct 1, 2023 to Feb 15, 2024
    • Eligibility criteria expanded, about 134 words
    • Study description expanded, about 16 words
    • Site details revised at 2 of 2 sites
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Bradley Hospital
13 trials monitored
See 2 trials at risk
Anxiety
3,263 trials monitored
See 159 trials at risk
The goal of this clinical trial is to compare different forms of transcranial magnetic stimulation (TMS) for improving the outcomes of Exposure with Response Prevention (ERP) in youth and young adults with Obsessive-Compulsive Disorder (OCD). Researchers will compare three groups: ERP with one of two different active ("real") forms of TMS vs. ERP with sham ("fake") TMS. The main questions this study aims to answer are: 1) whether TMS normalizes functioning in brain circuits that contribute to compulsive behavior, and 2) whether TMS reduces compulsions during ERP. Participants will: * Complete clinical interviews, questionnaires, and computerized tasks * Complete two MRIs (brain scans) * Receive daily TMS followed by ERP for two weeks (10 sessions)
Trial Details
NCT Number NCT05931913
Lead Sponsor Bradley Hospital
Collaborators: University of Minnesota, Butler Hospital
Conditions
(from sponsor)		 Obsessive-Compulsive Disorder
Related terms Obsessive-Compulsive Disorder
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov